0001209191-19-049104.txt : 20190910 0001209191-19-049104.hdr.sgml : 20190910 20190910210311 ACCESSION NUMBER: 0001209191-19-049104 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190909 FILED AS OF DATE: 20190910 DATE AS OF CHANGE: 20190910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SPECTOR STEVEN W CENTRAL INDEX KEY: 0001170362 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31161 FILM NUMBER: 191087026 MAIL ADDRESS: STREET 1: ARENA PHARMACEUTICALS INC STREET 2: 6166 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARENA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001080709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232908305 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6154 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-453-7200 MAIL ADDRESS: STREET 1: 6154 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-09-09 0 0001080709 ARENA PHARMACEUTICALS INC ARNA 0001170362 SPECTOR STEVEN W C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 0 1 0 0 EVP, General Counsel & Sec Common Stock 2019-09-09 4 M 0 3274 32.50 A 22964 D Common Stock 2019-09-09 4 M 0 5810 17.90 A 28774 D Common Stock 2019-09-09 4 M 0 12373 15.50 A 41147 D Common Stock 2019-09-09 4 S 0 21200 50.4758 D 19947 D Common Stock 2019-09-09 4 S 0 10257 51.2263 D 9690 D Common Stock 2019-09-10 4 M 0 12627 15.50 A 22317 D Common Stock 2019-09-10 4 S 0 12627 50.279 D 9690 D Employee Stock Option (right to buy) 32.50 2019-09-09 4 M 0 3274 0.00 D 2020-03-17 Common Stock 3274 3726 D Employee Stock Option (right to buy) 17.90 2019-09-09 4 M 0 5810 0.00 D 2022-12-15 Common Stock 5810 9189 D Employee Stock Option (right to buy) 15.50 2019-09-09 4 M 0 12373 0.00 D 2023-03-02 Common Stock 12373 40127 D Employee Stock Option (right to buy) 15.50 2019-09-10 4 M 0 12627 0.00 D 2023-03-02 Common Stock 12627 27500 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.99, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes 2, 3, and 4 to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.59, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.59, inclusive. The options vested in four equal annual installments beginning on March 17, 2011, and were immediately exercisable once vested. The options vest in four equal annual installments beginning on December 15, 2016, and are immediately exercisable once vested. The options vest in four equal annual installments beginning on March 2, 2017, and are immediately exercisable once vested. /s/ Andrew J. Cronauer, as Attorney-in-Fact 2019-09-10